Authors


Laura Alfonso, BSN, RN, OCN

Latest:

High-Touch Wipe Down: Decreasing C. diff Rates in Adults With Cancer

Following a high rate of CDIs, the inpatient medical oncology unit at the University of California, Los Angeles, Santa Monica Medical Center adapted an evidence-based intervention.


Louise Eaton, RN, BSN, OCN

Latest:

Adhering to New Lifestyles for Caregivers and Patients Undergoing Stem Cell Transplants

Louise Eaton, RN, BSN, OCN, inpatient Stem Cell Transplant Unit, John Theurer Cancer Center, provides advice for the relationship between caregivers and patients undergoing stem cell transplantation, as well as responsibilities for caregivers.


Mikel Ross, BSN, RN, OCN

Latest:

Mikel Ross on the Cost of Cooling Caps for Chemotherapy Induced Hair Loss

Mikel Ross discusses the different costs of cooling cap interventions for chemotherapy-induced hair loss and insurance coverage.


Richard Joseph, MD

Latest:

Richard Joseph on Mucosal Melanoma

Richard Joseph, MD, an oncologist at Mayo Clinic, discusses mucosal melanoma.


Ellen Rice Tichich, MFA, MSN, RN, NPD-BC

Latest:

Bladder-Preserving Options in Bladder Cancer

Research is focusing more on the realities of a cystectomy and how to improve treatment options.


Kathrin Milbury, PhD

Latest:

Kathrin Milbury on the Importance of Spousal Self Care

Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses the importance of spouse and caregiver self care when tending to someone with lung cancer.


Kristen Nicastro, RN, BSN, OCN, Reiki Master

Latest:

Reiki's Place in Cancer Care

Complementary therapies in cancer care are on the rise. With their hospital's blessing and support, 2 nurses have been providing free Reiki to patients for 10 years as part of their approach to care.


Jill Stein

Latest:

Nab-Paclitaxel Boosts Survival in Pancreatic Cancer

The addition of albumin-bound paclitaxel (nab-paclitaxel) to the treatment standard gemcitabine significantly lengthened survival in patients with metastatic pancreatic cancer


MMRF

Latest:

Multiple Myeloma Research Foundation Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management

The MMRF was honored for the 15th year for outstanding stewardship of donors’ funds.


Steven M. Horwitz, MD

Latest:

Dr. Horwitz on Updates in T-Cell Lymphoma Treatment

Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses some new treatments on the horizon for T-cell lymphoma.


Nirali N. Shah, MD, MHSc

Latest:

Moving Therapies From the Relapse/Refractory Setting to the Frontline

Pediatric patients with ALL can expect therapies to help target their disease after they relapse, but experts are looking to combat the disease in the frontline before that.


Sheila Hunt, RN

Latest:

Sheila Hunt on Reducing Stress as an Oncology Nurse

Sheila Hunt, RN, Baylor Scott and White McClinton Cancer Center, discusses how she manages day-to-day stress as an oncology nurse.


Dorothy N. Pierce

Latest:

Dorothy N. Pierce on Advanced Practice Nurse Care in Radiation Oncology

Dorothy N. Pierce, APN-C, RN, Rutgers Cancer Institute of New Jersey, provides an overview of advanced practice nurse care in radiation oncology.


Christopher Pirschel, Staff Writer, Oncology Nursing Society

Latest:

Higher Nursing Education Translates to Better Care for Patients

For clinical nurse specialist and Oncology Nursing Society (ONS) member Anne Kolenic, DNP, APRN, AOCNS, her decision to pursue a DNP degree meant taking critical research results and implementing them to improve care at her institution.


David A. Bond, MD

Latest:

Do BTK Inhibitors Lead to Secondary Cancers?

Patients with CLL prescribed BTK inhibitors may have a higher chance of developing secondary cancers, according to recent research.


Mary Gullatte, PhD, RN, APRN, BC, AOCN, FAAN

Latest:

Mary Gullatte on the Impact of Oncology Nurses on Patients

Mary Gullatte, president of the Oncology Nursing Society, explains the impact that oncology nurses have on the lives of both patients and their families.


Anne Kirchhoff, PhD, MPH

Latest:

Supporting Adolescents and Young Adults With Cancer From Diagnosis Through Survivorship

Adolescents and young adults (AYAs) with cancer diagnosed between the ages of 15 and 39 are a unique group of patients with distinct cancer epidemiology and developmental characteristics.


By Marianne Davies, RN, MSN, ACNP, AOCNP

Latest:

Journal Club Bridges Research and Practice, Improving Patient Care

Three oncology nurses at the Smilow Cancer Hospital at Yale-New Haven write about the Smilow Society, an interactive and innovative journal club enabling nurses to stay abreast of important research developments, which can then be translated directly into clinical practice.


Rachel Narozniak, MA

Latest:

COVID-19 Pandemic Boosts Cancer-Related Stress

Patients on active therapy during the coronavirus disease 2019 (COVID-19) pandemic, as well as oncology care providers, have increased levels of perceived and posttraumatic stress, according to preliminary data from the COVIPACT study. These data highlight a gap in psychosocial support resources that help promote emotional resilience and reduce the risk of posttraumatic stress in patients on active therapy.


Gwendolyn Quinn, PhD

Latest:

Gwendolyn Quinn on Educating Nurses and Physicians About Reproductive Health

Gwendolyn Quinn, PhD, discusses the importance of educating nurses and physicians about reproductive health.


Amanda Bontempo, MS, RD, CSO, CDN

Latest:

8 Simple Rules for Healthy Eating

Amanda Bontempo, MS, RD, CSO, CDN, gives some tips for healthy eating. Join us on 4/18 at 1 PM for our tweetchat, with Bontempo as moderator, to discuss more nutrition.


Jennie R. Crews, MD, MMM, FACP

Latest:

Improving Immunotherapy Implementation in Community Practice

The ACCC created the Immuno-Oncology Institute to help community practices address up-and-coming questions around immunotherapy implementation.


OncLive Staff

Latest:

FDA Granted Enzalutamide Priority Review to Treat Metastatic Hormone-Sensitive Prostate Cancer

The FDA has granted a priority review designation to a supplemental new drug application for enzalutamide (Xtandi) for the treatment of men with metastatic hormone-sensitive prostate cancer (mHSPC), according to Astellas Pharma Inc. and Pfizer Inc., the codevelopers of the androgen receptor inhibitor.


Dellann Elliott Mydland

Latest:

Dellann Elliott Mydland on Testing Brain Tumor Tissue

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.


Dawn Hershman, MD, MS

Latest:

Dr. Hershman Discusses the HOPE Study

Dawn Hershman, MD, MS, medical oncologist, Columbia University Medical Center, discusses the HOPE Study, a randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer.


Theresa Brown, RN

Latest:

New Nurses, Don't Give Up

Now more than ever, it is important for new nurses to keep their head up and ensure that their voice is heard, according to Theresa Brown, RN.


Anthony Berberabe, MPH

Latest:

Real-World Data Support Enfortumab Vedotin for Urothelial Carcinoma Treatment

Real-world data demonstrate significant outcome improvements with enfortumab vedotin in patients with unresectable or metastatic urothelial carcinoma.


Mayra Lima, MSN, APRN, FNP-C

Latest:

Cancer Care During COVID-19: Nurses Share Their Perspectives

The pandemic may elicit fear, but nurses’ dedication to their patients remains steadfast.


Lee Greenberger, PhD

Latest:

Lee Greenberger on Newly Approved Drugs for Multiple Myeloma

Lee Greenberger, PhD, chief scientific officer, The Leukemia & Lymphoma Society, discusses new agents that were recently approved for multiple myeloma.


Jean Sellers, MSN, RN

Latest:

Navigating Sensitive Topics: From Food Security to Insurance Coverage

Find ways to bring up these topics in patient conversations, while mitigating feelings of shame.